Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry

by Callis Duffin, K., Chakravarty, S.D, Cronin, A., Fitzgerald, T., Malley, W., McLean, R.R, Merola, J.F, Rowland, K., Teeple, A., Uy, J., Van Voorhees, A.S, Walsh, J.A
Published 2022

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: Pooled results through week 5...

by Boehncke, W.-H, Chakravarty, S.D, Deodhar, A., Jiang, Y., Kollmeier, A.P, McInnes, I.B, Mease, P.J, Merola, J.F, Ritchlin, C.T, Schiopu, E., Shawi, M., Sheng, S., Tesser, J., Wang, Y., Xu, S., Xu, X.L
Published 2022